GERMANY –CureVac and GlaxoSmithKline have signed on to a German pandemic contingency plan to reserve mRNA production capacity for years to come as they take another stab at a second-generation…
Read MoreGSK, CureVac and BioNTech awarded German pandemic preparedness contracts
